← All trials
NCT02404311
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2015
- Primary completion
- Jan 1, 2017
- Completion date
- Jan 1, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 252
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- National Institute of Allergy and Infectious Diseases (NIAID)Lead sponsor
- Bill and Melinda Gates FoundationCollaborator
- HIV Vaccine Trials NetworkStudy chair
- HIV Vaccine Trials NetworkCollaborator
- Medical Research CouncilCollaborator
- Sanofi-AventisCollaborator
- NovartisCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.